CD4 and cancer: In clinical practice, the assessment of the levels and functional states of immune cells, such as CD3+ (representing mature T lymphocytes), CD4+ (which can enhance immune function), and CD8+ (inhibitory T lymphocytes), and the CD4+/CD8+ ratio, serves as an indirect reflection of the host’s immunological status and provides critical data for cancer treatment and prognostic evaluation.